The hope of a vaccine against cancer, the toxicity of certain flavors of electronic cigarettes and the origin of sudden infant death syndrome: here are the three main news of the day.
A promising vaccine against cancer soon to be tested on humans
An immune-boosting cancer treatment successfully tested in mice will soon enter human clinical trials. Injected into solid tumors in mice, the vaccine activated the immune system in a localized fashion, particularly targeting cancer cells and leaving healthy cells intact. The vaccine not only eliminated 97% of lymphomas in mice, but also eliminated secondary malignancies resulting from the original cancerous tumors. In addition, say the researchers, this treatment would be effective against several types of cancer. For more information, click here.
Electronic cigarettes: some flavors are more toxic than others
The vapers are more and more numerous in France. Many of them believe that the electronic cigarette is to date the best alternative to quitting smoking. Researchers in North Carolina, United States, have developed a new technique to detect the toxicity of e-liquids from electronic cigarettes and discovered that some fragrances are more toxic than others, as are two basic ingredients. . Find out which ones in our article.
Sudden infant death syndrome: a rare genetic mutation involved
Usually occurring before the age of 6 months, Sudden Infant Death Syndrome (SIDS) is the unexpected death of an apparently healthy infant while sleeping. The leading cause of post-neonatal infant mortality in high-income countries, there are around 500 per year in France. According to a study published on March 28 in the journal “The Lancet”, sudden infant death syndrome may in part be linked to a rare genetic mutation that affects the functioning of the respiratory muscles. The details and precautions to be taken are in our article.
.